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Plasma Vol (L/m3) Stroke Vol (mL) Cardiac Output (L/min)
Day BR‐5 BR+0 BR+3 BR‐5 BR+0 BR+3 BR‐5 BR+0 BR+3
Mean 2.90 2.49 2.86 79.73 68.13 70.40 4.78 4.48 4.54
CI +/‐ 95% 2.67/3.13 2.26/2.72 2.62/3.09 68.31/91.15 59.71/79.55 58.98/81.82 4.09/5.47 3.79/5.17 3.85/5.23
p (BR‐5/BR+3) 0.66 <0.01 0.08
p (BR‐5/BR+0) <0.01 <0.01 0.03
Measure Heart Rate (bpm) Systolic BP (mmHg) Diastolic BP (mmHg)
Day BR‐5 BR+0 BR+3 BR‐5 BR+0 BR+3 BR‐5 BR+0 BR+3
Mean 59.56 63.38 63.63 114.63 122.88 118.06 69.69 77.69 73.06
CI +/‐ 95% 54.84/64.29 58.65/68.10 58.90/68.35 110.69/118.56 118.94/126.80 114.13/121.99 66.86/72.51 74.86/80.51 70.23/75.89
p (BR‐5/BR+3) <0.01 0.07 <0.01
p (BR‐5/BR+0) <0.01 <0.01 <0.01
• 14 day 6° HDT bed rest (+14 days pre-bed rest & +7 
days post-bed rest).
• Nomenclature:
• 16 subjects: normotensive, non-smoker, normal 
weight/BMI
• Male: 12
• Female: 4
• Statistical modeling performed using mixed effects linear 
regression model with random intercepts for subject and 
eye (L/R) to account for the within subjects experimental 
design (software package: Stata/IC 12.1).
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BACKGROUND RESULTSRESULTS
From Mader et al. Ophthalmology 2011;118(10):2058-69
• History of visual impairment among astronauts with
microgravity exposure.
• Numerous signs comprise the Visual 
Impairment/Intracranial Pressure (VIIP) syndrome. (below)
• Lack of data and analog studies have hindered 
development of preventive countermeasures.
• Current theory on VIIP etiology involves interaction of 
increased intraocular pressure (IOP), intracranial pressure 
(ICP), and genetic susceptibility.
PURPOSE
• Characterize HDT BR as possible VIIP syndrome model. 
• Investigate association between ocular/cardiovascular 
parameters.
METHOD
CONCLUSIONS
Fig. 3. Summary of cardiovascular deconditioning. These measures were
collected before and after bed rest (BR-5, BR+0, BR+3). Stroke volume, plasma
volume, and cardiac output all documented decreases from pre-bed rest
values. Heart rate and both systolic and diastolic blood pressure values
increased over their baseline values. Mixed effects linear regression modeling
was performed to determine the estimated means and confidence internals (CI)
of each measure.
• Mean IOP significantly increased while at 6° HDT and 
returned towards pre-bed rest values upon leaving bed 
rest. 
• While mean IOP increased during bed rest, it remained 
within the normal limits for subject safety. 
• A diuretic shift and cardiovascular deconditioning 
occurs during in-bed rest, as expected.
• There was no demonstrable correlation between the 
largest change in IOP (pre/post) and cardiovascular 
measure changes (pre/post).
• Additional mixed effects linear regression modeling may 
reveal some subclinical physiological changes that might 
assist in describing the VIIP syndrome pathophysiology.
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Standardized Conditions
• During in-bed phase: subject reclined and 
monitored 24 hours/day
• Vitals, body weight, fluid intake/output measured 
daily
• Awake time: 6:00 am – 10:00 pm
• Standardized diet to maintain weight within 3% of 
initial weight
DECREASE INCREASE
Fig. 1. IOP changes during pre-/in-/post-bed rest. Each circle represents IOP from either eye (left/right)
and is labeled with a letter notating each different test subject. A 95% confidence interval (CI) is
labeled at each point with the all-subject mean at the center. Average mean trending is indicated by
the line connecting data points. IOP was measured for all subjects using Goldmann applanation (pre-
/post-), iCARE (in-bed, 11 subjects), and Tonopen (in-bed, 5 subjects). Tonopen used for 5 subjects
due to delays in procuring iCARE. RNFL thickness changes were determined via spectral-domain
optical coherence tomography (OCT). No statistically significant changed was measured. A
statistically significant decrease in central subfield thickness (macula) was determined using Cirrus
HD-OCT (Carl Zeiss Meditec, Dublin, CA; vers. 5.0).
IOP Average RNFL Thickness
Central Subfield 
Thickness
Day BR‐10 BR‐3 BR3 BR10 BR+2 Pre Post Pre Post
Mean 13.30 13.78 15.28 15.20 14.09 93.41 93.72 260.31 258.44
CI +/‐ 95% 11.56/15.05 12.03/15.53 13.53/17.03 13.45/16.95 12.34/15.83 89.71/97.10 90.02/97.41 250.00/270.63 248.12/268.75
p (vs. BR‐3) 0.25 ‐ <0.01 <0.01 0.47 0.48 <0.01
• Mean IOP at BR3 increased over baseline values from BR-3               
(p < 0.01).
• Mean IOP at BR10 remained higher than baseline values from BR-3   
(p < 0.01).
• Mean IOP approached baseline values by BR+2 and was no longer 
elevated at a statistically significant level (p < 0.47).
• Although mean IOP increased during the 6 HDT in-bed phase, it 
remained within the normal limits for subject safety. 
• Analysis of RNFL Thickness with Cirrus HD-OCT showed no 
statistically significant changes (p < 0.48).
• Central subfield (macula) thickness decreased from an average of 
260.31 μm at BR-10 to an average of 258.44 μm at BR+2 with statistical 
significance (p < 0.01). 
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• No data available relating fluid shifts to changes in IOP 
during in-bed rest due to experimental design of the 
study.
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• No significant correlation was found between IOP and cardiovascular 
changes using a Somers’s d non-parametric measure of association.  
Variable
(vs. IOP) Coefficient Standard Error p
PV -0.14 0.23 0.54
SV 0.11 0.23 0.62
HR 0.15 0.28 0.58
SBP 0.02 0.21 0.93
DBP -0.26 0.23 0.62
Fig. 2. A Somers’s d non-parametric measure of association was used to assess correlation between
changes in intraocular pressure (IOP) and cardiovascular (CV) variables. No statistically significant p
values were seen when comparing all of the CV variables (Plasma Volume/PV, Stroke Volume/SV,
Heart Rate/HR, Systolic Blood Pressure/SBP, Diastolic Blood Pressure/DBP) to IOP.
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